US Stock MarketDetailed Quotes

CRXTQ CLARUS THERAPEUTICS HLDGS INC

Watchlist
  • 0.001
  • 0.0000.00%
15min DelayTrading Mar 1 16:00 ET
72.83KMarket Cap-2P/E (TTM)

About CLARUS THERAPEUTICS HLDGS INC Company

Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company is focused on focused on the commercialization of JATENZO (testosterone undecanoate), the first and only oral testosterone replacement, or testosterone replacement therapy, and JATENZO is the sole source of company's revenue.

Company Profile

SymbolCRXTQ
Company NameCLARUS THERAPEUTICS HLDGS INC
CEODr. Robert E. Dudley
MarketPink Market
Employees16
Securities TypeOrdinary Shares
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Robert E. Dudley
  • Director, President and Chief Executive Officer
  • 2.55M
  • Steven A. Bourne
  • Chief Administrative Officer, Secretary and Treasurer
  • --
  • Richard D. Peterson
  • Chief Financial Officer and Principal Accounting Officer
  • 1.11M
  • Frank Jaeger
  • Chief Commercial Officer
  • 885.27K
  • Kimberly M. Murphy
  • Chairman of the Board
  • 74.79K
  • Mark A. Prygocki, Sr
  • Independent Director
  • 183.13K
  • John Kenneth Amory
  • Independent Director
  • 63.17K
  • Elizabeth A. Cermak
  • Independent Director
  • 67.82K
  • Alex Zisson
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg